Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$26K Sell
5,500
-30,100
-85% -$4.04M 0.04% 155
2017
Q2
$201K Sell
35,600
-3,600
-9% -$486K 0.35% 58
2017
Q1
$120K Buy
39,200
+8,000
+26% +$1.04M 0.16% 107
2016
Q4
$110K Buy
+31,200
New +$3.68M 0.13% 96
2016
Q2
Sell
-5,000
Closed -$5K 356
2016
Q1
$5K Buy
+5,000
New +$636K 0.01% 268

Other funds holding CLX

FT Options's CLX Position: Q3 2017 in Review

FT Options reduced its Clorox (CLX) stake by 75% in Q3 2017, selling an estimated $971K and leaving 2,400 shares worth $317K. The position accounts for 0.48% of the portfolio, ranked #53.

FT Options first reported a position in CLX in Q4 2016 and has held it in 3 quarters since. The position peaked at $1.28M in Q2 2017. 857 funds tracked by Wall St. Rank hold CLX as of Q3 2017.

  • FT Options held 2,400 shares of Clorox worth $317K as of Q3 2017.
  • FT Options sold 7,223 Clorox shares in Q3 2017, an estimated $971K.
  • Clorox made up 0.48% of FT Options's portfolio in Q3 2017, its #53 holding.
  • FT Options first reported a position in Clorox in Q4 2016 and has held it in 3 quarters since.
  • FT Options's Clorox position peaked at $1.28M in Q2 2017.
  • 857 funds tracked by Wall St. Rank held Clorox as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.